Search

Your search keyword '"Shea, Thomas C."' showing total 698 results
Start Over Author "Shea, Thomas C."
698 results on '"Shea, Thomas C."'

1. Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30+ lymphoma: a phase 1 study

Author

Grover, Natalie S, Hucks, George, Riches, Marcie L, Ivanova, Anastasia, Moore, Dominic T, Shea, Thomas C, Seegars, Mary Beth, Armistead, Paul M, Kasow, Kimberly A, Beaven, Anne W, Dittus, Christopher, Coghill, James M, Jamieson, Katarzyna J, Vincent, Benjamin G, Wood, William A, Cheng, Catherine, Morrison, Julia Kaitlin, West, John, Cavallo, Tammy, Dotti, Gianpietro, Serody, Jonathan S, and Savoldo, Barbara

Published
2024
Full Text
View/download PDF

2. Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice

Author

Stadtmauer, Edward A, Sullivan, Keith M, Idrissi, Mohamed El, Salaun, Bruno, Alonso, Aránzazu Alonso, Andreadis, Charalambos, Anttila, Veli-Jukka, Bloor, Adrian JC, Broady, Raewyn, Cellini, Claudia, Cuneo, Antonio, Dagnew, Alemnew F, Di Paolo, Emmanuel, Eom, HyeonSeok, González-Rodríguez, Ana Pilar, Grigg, Andrew, Guenther, Andreas, Heineman, Thomas C, Jarque, Isidro, Kwak, Jae-Yong, Lucchesi, Alessandro, Oostvogels, Lidia, Zarzuela, Marta Polo, Schuind, Anne E, Shea, Thomas C, Sinisalo, Ulla Marjatta, Vural, Filiz, San Segundo, Lucrecia Yáñez, Zachée, Pierre, and Bastidas, Adriana

Subjects
Clinical Research, Rare Diseases, Cancer, Immunization, Prevention, Clinical Trials and Supportive Activities, Hematology, Lymphoma, Vaccine Related, Stem Cell Research, Transplantation, 6.2 Cellular and gene therapies, Evaluation of treatments and therapeutic interventions, Good Health and Well Being, Hematopoietic Stem Cell Transplantation, Herpes Zoster, Herpes Zoster Vaccine, Herpesvirus 3, Human, Humans, Immunity, Cellular, Vaccine Efficacy, Autologous hematopoietic stem cell transplant, cell-mediated immunity, polyfunctionality, humoral immune response, adjuvanted recombinant zoster vaccine, vaccine efficacy, Immunology, Medical Microbiology, Pharmacology and Pharmaceutical Sciences, Virology
Abstract

Immunocompromised individuals, particularly autologous hematopoietic stem cell transplant (auHSCT) recipients, are at high risk for herpes zoster (HZ). We provide an in-depth description of humoral and cell-mediated immune (CMI) responses by age (protocol-defined) or underlying disease (post-hoc) as well as efficacy by underlying disease (post-hoc) of the adjuvanted recombinant zoster vaccine (RZV) in a randomized observer-blind phase III trial (ZOE-HSCT, NCT01610414). 1846 adult auHSCT recipients were randomized to receive a first dose of either RZV or placebo 50-70 days post-auHSCT, followed by the second dose at 1-2 months (M) later. In cohorts of 114-1721 participants, at 1 M post-second vaccine dose: Anti-gE antibody geometric mean concentrations (GMCs) and median gE-specific CD4[2+] T-cell frequencies (CD4 T cells expressing ≥2 of four assessed activation markers) were similar between 18-49 and ≥50-year-olds. Despite lower anti-gE antibody GMCs in non-Hodgkin B-cell lymphoma (NHBCL) patients, CD4[2+] T-cell frequencies were similar between NHBCL and other underlying diseases. The proportion of polyfunctional CD4 T cells increased over time, accounting for 79.6% of gE-specific CD4 T cells at 24 M post-dose two. Vaccine efficacy against HZ ranged between 42.5% and 82.5% across underlying diseases and was statistically significant in NHBCL and multiple myeloma patients. In conclusion, two RZV doses administered early post-auHSCT induced robust, persistent, and polyfunctional gE-specific immune responses. Efficacy against HZ was also high in NHBCL patients despite the lower humoral response.

Published
2021

10. Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60–75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study

Author

Ustun, Celalettin, Le-Rademacher, Jennifer, Wang, Hai-Lin, Othus, Megan, Sun, Zhuoxin, Major, Brittny, Zhang, Mei-Jie, Storrick, Elizabeth, Lafky, Jacqueline M., Chow, Selina, Mrózek, Krzysztof, Attar, Eyal C., Nand, Such, Bloomfield, Clara D., Cripe, Larry D., Tallman, Martin S., Appelbaum, Frederick, Larson, Richard A., Marcucci, Guido, Roboz, Gail J., Uy, Geoffrey L., Stone, Richard M., Jatoi, Aminah, Shea, Thomas C., de Lima, Marcos, Foran, James M., Sandmaier, Brenda M., Litzow, Mark R., Erba, Harry P., Hurria, Arti, Weisdorf, Daniel J., and Artz, Andrew S.

Published
2019
Full Text
View/download PDF

11. Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30+lymphoma: a phase 1 study

Author

Grover, Natalie S, Hucks, George, Riches, Marcie L, Ivanova, Anastasia, Moore, Dominic T, Shea, Thomas C, Seegars, Mary Beth, Armistead, Paul M, Kasow, Kimberly A, Beaven, Anne W, Dittus, Christopher, Coghill, James M, Jamieson, Katarzyna J, Vincent, Benjamin G, Wood, William A, Cheng, Catherine, Morrison, Julia Kaitlin, West, John, Cavallo, Tammy, Dotti, Gianpietro, Serody, Jonathan S, and Savoldo, Barbara

Abstract

Chimeric antigen receptor (CAR) T cells targeting CD30 are safe and have promising activity when preceded by lymphodepleting chemotherapy. We aimed to determine the safety of anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation (HSCT) in patients with CD30+lymphoma at high risk of relapse.

Published
2024
Full Text
View/download PDF

13. Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis

Author

Wood, William A., Brazauskas, Ruta, Hu, Zhen-Huan, Abdel-Azim, Hisham, Ahmed, Ibrahim A., Aljurf, Mahmoud, Badawy, Sherif, Beitinjaneh, Amer, George, Biju, Buchbinder, David, Cerny, Jan, Dedeken, Laurence, Diaz, Miguel Angel, Freytes, Cesar O., Ganguly, Siddhartha, Gergis, Usama, Almaguer, David Gomez, Gupta, Ashish, Hale, Gregory, Hashmi, Shahrukh K., Inamoto, Yoshihiro, Kamble, Rammurti T., Adekola, Kehinde, Kindwall-Keller, Tamila, Knight, Jennifer, Kumar, Lalit, Kuwatsuka, Yachiyo, Law, Jason, Lazarus, Hillard M., LeMaistre, Charles, Olsson, Richard F., Pulsipher, Michael A., Savani, Bipin N., Schultz, Kirk R., Saad, Ayman A., Seftel, Matthew, Seo, Sachiko, Shea, Thomas C., Steinberg, Amir, Sullivan, Keith, Szwajcer, David, Wirk, Baldeep, Yared, Jean, Yong, Agnes, Dalal, Jignesh, Hahn, Theresa, Khera, Nandita, Bonfim, Carmem, Atsuta, Yoshiko, and Saber, Wael

Published
2018
Full Text
View/download PDF

14. Supplementary Tables 1 - 4, Figures 1 - 2 from Peptide/MHC Tetramer–Based Sorting of CD8+ T Cells to a Leukemia Antigen Yields Clonotypes Drawn Nonspecifically from an Underlying Restricted Repertoire

Author

Hunsucker, Sally A., primary, McGary, Colleen S., primary, Vincent, Benjamin G., primary, Enyenihi, Atim A., primary, Waugh, Jennifer P., primary, McKinnon, Karen P., primary, Bixby, Lisa M., primary, Ropp, Patricia A., primary, Coghill, James M., primary, Wood, William A., primary, Gabriel, Don A., primary, Sarantopoulos, Stefanie, primary, Shea, Thomas C., primary, Serody, Jonathan S., primary, Alatrash, Gheath, primary, Rodriguez-Cruz, Tania, primary, Lizée, Gregory, primary, Buntzman, Adam S., primary, Frelinger, Jeffrey A., primary, Glish, Gary L., primary, and Armistead, Paul M., primary

Published
2023
Full Text
View/download PDF

15. Data from Peptide/MHC Tetramer–Based Sorting of CD8+ T Cells to a Leukemia Antigen Yields Clonotypes Drawn Nonspecifically from an Underlying Restricted Repertoire

Author

Hunsucker, Sally A., primary, McGary, Colleen S., primary, Vincent, Benjamin G., primary, Enyenihi, Atim A., primary, Waugh, Jennifer P., primary, McKinnon, Karen P., primary, Bixby, Lisa M., primary, Ropp, Patricia A., primary, Coghill, James M., primary, Wood, William A., primary, Gabriel, Don A., primary, Sarantopoulos, Stefanie, primary, Shea, Thomas C., primary, Serody, Jonathan S., primary, Alatrash, Gheath, primary, Rodriguez-Cruz, Tania, primary, Lizée, Gregory, primary, Buntzman, Adam S., primary, Frelinger, Jeffrey A., primary, Glish, Gary L., primary, and Armistead, Paul M., primary

Published
2023
Full Text
View/download PDF

16. Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial

Author

Holstein, Sarah A, Jung, Sin-Ho, Richardson, Paul G, Hofmeister, Craig C, Hurd, David D, Hassoun, Hani, Giralt, Sergio, Stadtmauer, Edward A, Weisdorf, Daniel J, Vij, Ravi, Moreb, Jan S, Callander, Natalie S, van Besien, Koen, Gentile, Teresa G, Isola, Luis, Maziarz, Richard T, Bashey, Asad, Landau, Heather, Martin, Thomas, Qazilbash, Muzaffar H, Rodriguez, Cesar, McClune, Brian, Schlossman, Robert L, Smith, Scott E, Hars, Vera, Owzar, Kouros, Jiang, Chen, Boyd, Molly, Schultz, Chelsea, Wilson, Marcia, Hari, Parameswaran, Pasquini, Marcelo C, Horowitz, Mary M, Shea, Thomas C, Devine, Steven M, Linker, Charles, Anderson, Kenneth C, and McCarthy, Philip L

Published
2017
Full Text
View/download PDF

19. Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes

Author

Flowers, Christopher R., Costa, Luciano J., Pasquini, Marcelo C., Le-Rademacher, Jennifer, Lill, Michael, Shore, Tsiporah B., Vaughan, William, Craig, Michael, Freytes, Cesar O., Shea, Thomas C., Horwitz, Mitchell E., Fay, Joseph W., Mineishi, Shin, Rondelli, Damiano, Mason, James, Braunschweig, Ira, Ai, Weiyun, Yeh, Rosa F., Rodriguez, Tulio E., Flinn, Ian, Comeau, Terrance, Yeager, Andrew M., Pulsipher, Michael A., Bence-Bruckler, Isabelle, Laneuville, Pierre, Bierman, Philip, Chen, Andy I., Kato, Kazunobu, Wang, Yanlin, Xu, Cong, Smith, Angela J., and Waller, Edmund K.

Published
2016
Full Text
View/download PDF

22. Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma: Guidelines from the American Society for Blood and Marrow Transplantation

Author

Perales, Miguel-Angel, Ceberio, Izaskun, Armand, Philippe, Burns, Linda J., Chen, Robert, Cole, Peter D., Evens, Andrew M., Laport, Ginna G., Moskowitz, Craig H., Popat, Uday, Reddy, Nishitha M., Shea, Thomas C., Vose, Julie M., Schriber, Jeffrey, Savani, Bipin N., and Carpenter, Paul A.

Published
2015
Full Text
View/download PDF

24. Increased BCR responsiveness in B cells from patients with chronic GVHD

Author

Allen, Jessica L., Tata, Prasanthi V., Fore, Matthew S., Wooten, Jenna, Rudra, Sharmistha, Deal, Allison M., Sharf, Andrew, Hoffert, Todd, Roehrs, Philip A., Shea, Thomas C., Serody, Jonathan S., Richards, Kristy L., Jagasia, Madan, Lee, Stephanie J., Rizzieri, David, Horwitz, Mitchell E., Chao, Nelson J., and Sarantopoulos, Stefanie

Published
2014
Full Text
View/download PDF

26. Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma

Author

Matasar, Matthew J., Czuczman, Myron S., Rodriguez, Maria Alma, Fennessy, Michael, Shea, Thomas C., Spitzer, Gary, Lossos, Izidore S., Kharfan-Dabaja, Mohamed A., Joyce, Robin, Fayad, Luis, Henkel, Kristen, Liao, Qiming, Edvardsen, Klaus, Jewell, Roxanne C., Fecteau, Doug, Singh, Rajendra P., Lisby, Steen, and Moskowitz, Craig H.

Published
2013
Full Text
View/download PDF

28. RB but not R‐HCVAD is a feasible induction regimen prior to auto‐HCT in frontline MCL: results of SWOG Study S1106

Author

Chen, Robert W., Li, Hongli, Bernstein, Steven H., Kahwash, Samir, Rimsza, Lisa M., Forman, Stephen J., Constine, Louis, Shea, Thomas C., Cashen, Amanda F., Blum, Kristie A., Fenske, Timothy S., Barr, Paul M., Phillips, Tycel, Leblanc, Michael, Fisher, Richard I., Cheson, Bruce D., Smith, Sonali M., Faham, Malek, Wilkins, Jennifer, Leonard, John P., Kahl, Brad S., and Friedberg, Jonathan W.

Published
2017
Full Text
View/download PDF

29. B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways

Author

Allen, Jessica L., Fore, Matthew S., Wooten, Jenna, Roehrs, Philip A., Bhuiya, Nazmim S., Hoffert, Todd, Sharf, Andrew, Deal, Allison M., Armistead, Paul, Coghill, James, Gabriel, Don A., Irons, Robert, Essenmacher, Amber, Shea, Thomas C., Richards, Kristy, Cutler, Corey, Ritz, Jerome, Serody, Jonathan, Baldwin, Albert S., and Sarantopoulos, Stefanie

Published
2012
Full Text
View/download PDF

32. Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Patients with Hematologic Malignancies Who Relapse following Autologous Transplantation: A Multi-institutional Prospective Study from the Cancer and Leukemia Group B (CALGB trial 100002)

Author

Bashey, Asad, Owzar, Kouros, Johnson, Jeffrey L., Edwards, Peggy S., Kelly, Michael, Baxter-Lowe, Lee-Ann, Devine, Steven, Farag, Sherif, Hurd, David, Ball, Edward, McCarthy, Philip, Lister, John, Shea, Thomas C., and Linker, Charles

Published
2011
Full Text
View/download PDF

33. CD30-Directed Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Hodgkin Lymphoma and Non-Hodgkin Lymphoma in Pediatric Patients

Author

Hucks, George E., primary, Savoldo, Barbara, additional, Dotti, Gianpietro, additional, Cheng, Catherine Joyce Arago, additional, Babinec, Caroline, additional, Kasow, Kimberly A., additional, Winstead, Michael, additional, Patel, Arpita, additional, Presler, Cammie, additional, Grover, Natalie S, additional, Morrison, J. Kaitlin, additional, Beaven, Anne W., additional, Riches, Marcie L., additional, Shea, Thomas C., additional, and Serody, Jonathan S., additional

Published
2021
Full Text
View/download PDF

35. P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808

Author

Kolitz, Jonathan E., George, Stephen L., Marcucci, Guido, Vij, Ravi, Powell, Bayard L., Allen, Steven L., DeAngelo, Daniel J., Shea, Thomas C., Stock, Wendy, Baer, Maria R., Hars, Vera, Maharry, Kati, Hoke, Eva, Vardiman, James W., Bloomfield, Clara D., and Larson, Richard A.

Published
2010
Full Text
View/download PDF

36. A Comparison of HLA-Identical Sibling Allogeneic versus Autologous Transplantation for Diffuse Large B Cell Lymphoma: A Report from the CIBMTR

Author

Lazarus, Hillard M., Zhang, Mei-Jie, Carreras, Jeanette, Hayes-Lattin, Brandon M., Ataergin, Asli Selmin, Bitran, Jacob D., Bolwell, Brian J., Freytes, César O., Gale, Robert Peter, Goldstein, Steven C., Hale, Gregory A., Inwards, David J., Klumpp, Thomas R., Marks, David I., Maziarz, Richard T., McCarthy, Philip L., Pavlovsky, Santiago, Rizzo, J. Douglas, Shea, Thomas C., Schouten, Harry C., Slavin, Shimon, Winter, Jane N., van Besien, Koen, Vose, Julie M., and Hari, Parameswaran N.

Published
2010
Full Text
View/download PDF

39. Impact of Pre-transplant Rituximab on Survival after Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B Cell Lymphoma

Author

Fenske, Timothy S., Hari, Parameswaran N., Carreras, Jeanette, Zhang, Mei-Jie, Kamble, Rammurti T., Bolwell, Brian J., Cairo, Mitchell S., Champlin, Richard E., Chen, Yi-Bin, Freytes, César O., Gale, Robert Peter, Hale, Gregory A., Ilhan, Osman, Khoury, H. Jean, Lister, John, Maharaj, Dipnarine, Marks, David I., Munker, Reinhold, Pecora, Andrew L., Rowlings, Philip A., Shea, Thomas C., Stiff, Patrick, Wiernik, Peter H., Winter, Jane N., Rizzo, J. Douglas, van Besien, Koen, Lazarus, Hillard M., and Vose, Julie M.

Published
2009
Full Text
View/download PDF

40. Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice

Author

Stadtmauer, Edward A., Sullivan, Keith M., El Idrissi, Mohamed, Salaun, Bruno, Alonso Alonso, Aranzazu, Andreadis, Charalambos, Anttila, Veli-Jukka, Bloor, Adrian J. C., Broady, Raewyn, Cellini, Claudia, Cuneo, Antonio, Dagnew, Alemnew F., Di Paolo, Emmanuel, Eom, HyeonSeok, Gonzalez-Rodriguez, Ana Pilar, Grigg, Andrew, Gunther, Andreas, Heineman, Thomas C., Jarque, Isidro, Kwak, Jae-Yong, Lucchesi, Alessandro, Oostvogels, Lidia, Polo Zarzuela, Marta, Schuind, Anne E., Shea, Thomas C., Sinisalo, Ulla Marjatta, Vural, Filiz, Yanez San Segundo, Lucrecia, Zachee, Pierre, Bastidas, Adriana, and ZOE-SCT Study Grp Collaborators

Subjects
Autologous hematopoietic stem cell transplant, adjuvanted recombinant zoster vaccine, cell-mediated immunity, humoral immune response, polyfunctionality, vaccine efficacy
Abstract

Immunocompromised individuals, particularly autologous hematopoietic stem cell transplant (auHSCT) recipients, are at high risk for herpes zoster (HZ). We provide an in-depth description of humoral and cell-mediated immune (CMI) responses by age (protocol-defined) or underlying disease (post-hoc) as well as efficacy by underlying disease (post-hoc) of the adjuvanted recombinant zoster vaccine (RZV) in a randomized observer-blind phase III trial (ZOE-HSCT, NCT01610414). 1846 adult auHSCT recipients were randomized to receive a first dose of either RZV or placebo 50-70 days post-auHSCT, followed by the second dose at 1-2 months (M) later. In cohorts of 114-1721 participants, at 1 M post-second vaccine dose: Anti-gE antibody geometric mean concentrations (GMCs) and median gE-specific CD4[2+] T-cell frequencies (CD4 T cells expressing =2 of four assessed activation markers) were similar between 18-49 and =50-year-olds. Despite lower anti-gE antibody GMCs in non-Hodgkin B-cell lymphoma (NHBCL) patients, CD4[2+] T-cell frequencies were similar between NHBCL and other underlying diseases. The proportion of polyfunctional CD4 T cells increased over time, accounting for 79.6% of gE-specific CD4 T cells at 24 M post-dose two. Vaccine efficacy against HZ ranged between 42.5% and 82.5% across underlying diseases and was statistically significant in NHBCL and multiple myeloma patients. In conclusion, two RZV doses administered early post-auHSCT induced robust, persistent, and polyfunctional gE-specific immune responses. Efficacy against HZ was also high in NHBCL patients despite the lower humoral response.

Published
2021

41. Assessing the feasibility of a virtual tumor board program: a case study

Author

Shea, Christopher M., Teal, Randall, Haynes-Maslow, Lindsey, McIntyre, Molly, Weiner, Bryan J., Wheeler, Stephanie B., Jacobs, Sara R., Mayer, Deborah K., Young, Michael, and Shea, Thomas C.

Subjects
Cancer -- Care and treatment, Physicians -- Practice, Technology application, Business, Health care industry, University of North Carolina at Chapel Hill. UNC Lineberger Comprehensive Cancer Center -- Services
Abstract

EXECUTIVE SUMMARY Multidisciplinary tumor boards involve various providers (e.g., oncology physicians, nurses) in patient care. Although many community hospitals have local tumor boards that review all types of cases, numerous [...]

Published
2014

42. Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: Results from Cancer and Leukemia Group B 19808

Author

Kolitz, Jonathan E., George, Stephen L., Benson, Don M., Jr, Maharry, Kati, Marcucci, Guido, Vij, Ravi, Powell, Bayard L., Allen, Steven L., DeAngelo, Daniel J., Shea, Thomas C., Stock, Wendy, Bakan, Courtney E., Hars, Vera, Hoke, Eva, Bloomfield, Clara D., Caligiuri, Michael A., and Larson, Richard A.

Published
2014
Full Text
View/download PDF

45. Autologous Transplantation as Consolidation for Aggressive Non-Hodgkinʼs Lymphoma

Author

Stiff, Patrick J., Unger, Joseph M., Cook, James R., Constine, Louis S., Couban, Stephen, Stewart, Douglas A., Shea, Thomas C., Porcu, Pierluigi, Winter, Jane N., Kahl, Brad S., Miller, Thomas P., Tubbs, Raymond R., Marcellus, Deborah, Friedberg, Jonathan W., Barton, Kevin P., Mills, Glenn M., LeBlanc, Michael, Rimsza, Lisa M., Forman, Stephen J., and Fisher, Richard I.

Published
2013
Full Text
View/download PDF

47. Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma

Author

Ramos, Carlos A., primary, Grover, Natalie S., additional, Beaven, Anne W., additional, Lulla, Premal D., additional, Wu, Meng-Fen, additional, Ivanova, Anastasia, additional, Wang, Tao, additional, Shea, Thomas C., additional, Rooney, Cliona M., additional, Dittus, Christopher, additional, Park, Steven I., additional, Gee, Adrian P., additional, Eldridge, Paul W., additional, McKay, Kathryn L., additional, Mehta, Birju, additional, Cheng, Catherine J., additional, Buchanan, Faith B., additional, Grilley, Bambi J., additional, Morrison, Kaitlin, additional, Brenner, Malcolm K., additional, Serody, Jonathan S., additional, Dotti, Gianpietro, additional, Heslop, Helen E., additional, and Savoldo, Barbara, additional

Published
2020
Full Text
View/download PDF

50. Contributeurs

Author

Runge, Marschall S., primary, Greganti, M. Andrew, additional, Adimora, Adaora A., additional, Alattar, Maha, additional, Aris, Robert M., additional, Bae-Jump, Victoria Lin, additional, Baggstrom, Maria Q., additional, Barritt, A. Sidney, additional, Bassim, Marc K., additional, Bates, Toby, additional, Beaven, Anne W., additional, Berger, Robert G., additional, Berkowitz, Lee R., additional, Bernard, Stephen A., additional, Blau, William S., additional, Boggess, John F., additional, Bowman, Mary C., additional, Brecher, Mark E., additional, Bromberg, Philip A., additional, Brown, Sue A., additional, Brown, Vickie, additional, Bryson, Paul C., additional, Buckmire, Robert A., additional, Bullitt, Elizabeth, additional, Burkhart, Craig, additional, Busby-Whitehead, M. Janette, additional, Buse, John B., additional, Bynum, Debra L., additional, Carey, Lisa A., additional, Carey, Timothy S., additional, Carson, Culley C., additional, Chang, Patricia P., additional, Chaudhary, Sanjay, additional, Clemmons, David R., additional, Coghill, James M., additional, Colindres, Romulo E., additional, Connolly, AnnaMarie, additional, Copeland, Benjamin J., additional, Correll, Todd, additional, Denu-Ciocca, Cynthia J., additional, Devetski, Thomas S., additional, DeWalt, Darren A., additional, Diaz, Luis A., additional, Donohue, James F., additional, Dooley, Mary Anne, additional, Dostou, Jean M., additional, Drossman, Douglas A., additional, Dupree, Carla Sueta, additional, Eapen, Rose J., additional, Ebert, Charles S., additional, Erdem, Nurum F., additional, Eron, Joseph J., additional, Falk, Ronald J., additional, Farmer-Boatwright, Mary Katherine, additional, Fasy, Elizabeth A., additional, Finkel, Alan G., additional, Finn, William F., additional, Fitzgerald, David P., additional, Ford, Carol A., additional, Forneris, Catherine A., additional, Fowler, Amy M., additional, Fowler, W. Craig, additional, Fowler, Wesley Caswell, additional, Fried, Michael W., additional, Gabriel, Don A., additional, Galvin, Shannon, additional, Gangarosa, Lisa M., additional, Garbutt, James C., additional, Gay, Cynthia, additional, Gaylord, Susan A., additional, Gettes, Leonard S., additional, Ghio, Andrew J., additional, Gilmore, John H., additional, Godley, Paul A., additional, Goldberg, Lee R., additional, Goldberg, Richard M., additional, Goldenberg, Matthew N., additional, Goldstein, Brian P., additional, Greenwood, Robert S., additional, Grimm, Ian S., additional, Grossman, Steven H., additional, Gwyther, Robert E., additional, Haggerty, John J., additional, Harris, Russell P., additional, Heizer, William D., additional, Henderson, Ashley G., additional, Henke, David C., additional, Hill, Michael A., additional, Hinderliter, Alan L., additional, Hinn, Albert R., additional, Hladik, Gerald A., additional, Hoffman, Hal M., additional, Hosseinipour, Mina C., additional, Howard, James F., additional, Huang, David Y., additional, Huang, Xuemei, additional, Hutto, Burton R., additional, Isaacs, Kim L., additional, Israel, Bruce F., additional, Ivester, Thomas S., additional, Jacobe, Heidi T., additional, Jacobson, Peter Lars, additional, Jantac, Lukas, additional, Jawanda, Jaspaul S., additional, Johnson, Sandra M., additional, Jonas, Beth L., additional, Jordan, Joanne M., additional, Juliano, Jonathan J., additional, Kahn, Kevin A., additional, Kaplan, Andrew H., additional, Key, Nigel S., additional, Kim, William Y., additional, Kizer, John S., additional, Klein, Caroline M., additional, Klemmer, Philip J., additional, Kölln, Karen, additional, Koruda, Mark J., additional, Kurz, James E., additional, LaCour, Jeffrey, additional, Ladha, Alim M., additional, Leight, W. Derek, additional, Leone, Peter A., additional, Lindsey, B. Anthony, additional, Madanick, Ryan D., additional, Mandelkehr, Lawrence K., additional, Mann, J. Douglas, additional, Markovic-Plese, Silva, additional, Marshall, Allen F., additional, Mattern, William D., additional, Mayer, Celeste M., additional, Meredith, Travis A., additional, Miller, William C., additional, Mitchell, Beverly S., additional, Moll, Stephan, additional, Morgan, Douglas R., additional, Morrell, Dean S., additional, Muñoz, M. Cristina, additional, Nachman, Patrick H., additional, Nelson, Kelly C., additional, Nester, Carla M., additional, Nicholas, Linda M., additional, Ohman, E. Magnus, additional, O'Neil, Bert H., additional, Ontjes, David A., additional, Orlowski, Robert Z., additional, Parsons, Daniel J., additional, Patel, Dhavalkumar D., additional, Patterson, Cam, additional, Patterson, Kristine B., additional, Peppercorn, Amanda, additional, Pillsbury, Harold C., additional, Rathmell, W. Kimryn, additional, Reuland, Daniel S., additional, Ringel, Yehuda, additional, Rivera, M. Patricia, additional, Rosebrock, Craig N., additional, Rosenberg, Pinchas, additional, Roubey, Robert A.S., additional, Rubenstein, David S., additional, Runge, Susan Riggs, additional, Russo, Mark, additional, Rutala, William A., additional, Sanders, William E., additional, Sanoff, Hanna K., additional, Sanoff, Scott L., additional, Scarlett, Yolanda V., additional, Schwarz, Emily J., additional, Senior, Brent A., additional, Serody, Jonathan S., additional, Shaheen, Nicholas J., additional, Shea, Thomas C., additional, Sheahan, Richard G., additional, Shockley, William W., additional, Shrestha, Roshan, additional, Sickbert-Bennett, Emily E., additional, Sickel, Micah J., additional, Sikich, Linmarie, additional, Simpson, Ross J., additional, Smith, Sidney C., additional, Socinski, Mark A., additional, Sparling, P. Frederick, additional, Stinchcombe, Thomas E., additional, Stouffer, George A., additional, Tarrant, Teresa K., additional, Taylor, Mark, additional, Thomas, Michael J., additional, Thomas, Nancy E., additional, Thorpe, John M., additional, Tilley, Stephen L., additional, Ting, Jenny P., additional, Tomsick, Robert S., additional, van der Horst, Charles M., additional, Vaughn, Bradley V., additional, Vick, Pamela G., additional, Vissers, Robert J., additional, Voorhees, Peter M., additional, Wang, Tracy Y., additional, Watson, Lea C., additional, Weber, David J., additional, Wehbie, Robert S., additional, Weissler, Mark C., additional, Wells, Ellen C., additional, Whang, Young E., additional, Willis, Park W., additional, Winfield, John B., additional, Winzelberg, Gary S., additional, Wohl, David A., additional, Wong, Leslie P., additional, Wu, Diem N., additional, and Zacks, Steven, additional

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results